# VIVUS LLC clinical trials: 43 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 43 trials with VIVUS LLC as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by VIVUS LLC: 43 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/vivus-llc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 43
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 43, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 29, 2026 | NCT07612657 | A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional Limitations | VIVUS LLC | Phase 3 | Not yet recruiting | Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension (PAH) (WHO... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07612657) |
| April 8, 2025 | NCT06915246 | A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma | VIVUS LLC | Phase 2 | Recruiting | Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06915246) |
| January 31, 2022 | NCT05215418 | A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects | VIVUS LLC | Phase 4 | Completed | Blood Pressure | 565 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05215418) |
| April 22, 2019 | NCT03922945 | A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity | VIVUS LLC | Phase 4 | Completed | Adolescent Obesity, Obesity in Adolescence, Adolescent Overweight | 223 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03922945) |
| March 21, 2016 | NCT02714062 | A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents | VIVUS LLC | Phase 4 | Completed | Pediatric Obesity, Childhood Obesity | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02714062) |
| September 1, 2014 | NCT02229214 | Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects | VIVUS LLC | Phase 4 | Completed | Obesity | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02229214) |
| January 10, 2014 | NCT02033200 | Safety Study Looking at the Effects of Stendra on Vision | VIVUS LLC | Phase 4 | Completed | Vision | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02033200) |
| January 15, 2013 | NCT01768676 | Study Evaluating the Effects of Avanafil on Semen Parameters | VIVUS LLC | Phase 4 | Completed | Erectile Dysfunction | 181 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01768676) |
| October 3, 2012 | NCT01698684 | Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction | VIVUS LLC | Phase 4 | Completed | Erectile Dysfunction | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01698684) |
| June 11, 2012 | NCT01616485 | Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate... | VIVUS LLC | Phase 1 | Completed | Erectile Dysfunction | 106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01616485) |
| September 5, 2011 | NCT01428362 | VI-1121 for the Treatment Alzheimer's Disease | VIVUS LLC | Phase 2 | Completed | Alzheimer's Disease | 61 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01428362) |
| August 11, 2011 | NCT01415128 | Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male Subjects | VIVUS LLC | Phase 1 | Completed | Erectile Dysfunction | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01415128) |
| May 5, 2010 | NCT01117038 | Drug Interaction Study of Avanafil and Enalapril or Amlodipine | VIVUS LLC | Phase 1 | Completed | Erectile Dysfunction | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01117038) |
| April 8, 2010 | NCT01100021 | Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and Tamsulosin | VIVUS LLC | Phase 1 | Completed | Erectile Dysfunction | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01100021) |
| March 31, 2010 | NCT01096329 | A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa® | VIVUS LLC | Phase 1 | Terminated | Hypoactive Sexual Desire Disorder | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01096329) |
| March 30, 2010 | NCT01095601 | Assess the Effect of Food on Avanafil Pharmacokinetic (PK), to Compare 2 Oral Formulations of Avanafil,and Investigate Dose Proportionality... | VIVUS LLC | Phase 1 | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01095601) |
| March 30, 2010 | NCT01095588 | Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male Subjects | VIVUS LLC | Phase 1 | Completed | Erectile Dysfunction | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01095588) |
| January 22, 2010 | NCT01054859 | A Phase I Crossover Study of the Hemodynamic Interactions of Avanafil & Alcohol in Healthy Male Subjects. | VIVUS LLC | Phase 1 | Completed | Erectile Dysfunction | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01054859) |
| January 22, 2010 | NCT01054430 | To Assess the Safety of Avanafil in Healthy and Hepatically Impaired Male Subjects. | VIVUS LLC | Phase 1 | Completed | Erectile Dysfunction | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01054430) |
| January 22, 2010 | NCT01054261 | To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function. | VIVUS LLC | Phase 1 | Completed | Renal | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01054261) |
| June 5, 2009 | NCT00914511 | A Pharmacokinetic Study of Avanfil in Healthy Young Male Subjects | VIVUS LLC | Phase 1 | Completed | Avanfil ADME, Semen Exposure, Sperm Function | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00914511) |
| May 7, 2009 | NCT00895011 | Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy | VIVUS LLC | Phase 3 | Completed | Erectile Dysfunction | 298 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00895011) |
| March 2, 2009 | NCT00853606 | Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction | VIVUS LLC | Phase 3 | Completed | Erectile Dysfunction | 712 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00853606) |
| February 12, 2009 | NCT00842400 | A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects. | VIVUS LLC | Phase 1 | Completed | Obesity | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00842400) |
| February 10, 2009 | NCT00839891 | A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers | VIVUS LLC | Phase 1 | Completed | Torsades de Pointes | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00839891) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 19 |
| Phase 1/2 | 1 |
| Phase 2 | 7 |
| Phase 3 | 9 |
| Phase 4 | 7 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 39 |
| Terminated | 2 |
| Recruiting | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Erectile Dysfunction | 15 |
| Obesity | 11 |
| Diabetes Mellitus, Type 2 | 4 |
| Diabetes Mellitus | 3 |
| Overweight | 2 |
| Pediatric Obesity | 2 |
| Metabolic Diseases | 2 |
| Glucose Metabolism Disorders | 2 |
| Sexual Dysfunctions, Psychological | 1 |
| Weight Loss | 1 |
| Obesity, Morbid | 1 |
| Sexual Dysfunction, Physiological | 1 |
| Sleep Apnea Syndromes | 1 |
| Alzheimer Disease | 1 |
| Lymphoma | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Hodgkin Disease | 1 |
| Pulmonary Arterial Hypertension | 1 |
| Renal Insufficiency | 1 |
| Torsades de Pointes | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Electric utilities in the United States](https://specstream.ai/data/businesses/electric-utilities/united-states)
- [General dentistry practices in the United States](https://specstream.ai/data/businesses/general-dentistry-practices/united-states)
- [Inventory control companies in the United States](https://specstream.ai/data/businesses/inventory-control-companies/united-states)
- [Middle Eastern restaurants in the United States](https://specstream.ai/data/businesses/middle-eastern-restaurants/united-states)
- [Plastic and reconstructive surgery practices in the United States](https://specstream.ai/data/businesses/plastic-and-reconstructive-surgery-practices/united-states)
- [Seafood restaurants in the United States](https://specstream.ai/data/businesses/seafood-restaurants/united-states)
